The primary aim of this discussion paper is to assess the usefulness of the anti-Müllerian hormone assay procedure (AMH) with a view to its inclusion in the NABM (Nomenclature of Procedures in Laboratory Medicine).
See also
HAS opinions and decisions
26/07/2017
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
yQGnzTGBy0mWT4K0